A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

California Superior Court rules expert witnesses recruited by plaintiffs in a Zantac lawsuit can testify in case; Zantac maker GSK disagrees with ruling, which may be in conflict with US Federal Court that found Zantac lawsuits are based on flawed science
Published: March 27, 2023 by Daily Mail (London, England)
'Dry Liposome Adjuvant-Containing Vaccines And Related Methods Thereof' in Patent Application Approval Process (USPTO 20230060631)
Published: March 22, 2023 by NewsRx Pharma Business Daily
Reuters reports GSK, Moderna, CSL Seqirus all working on bird flu vaccinations for humans focused on currently circulating bird flu subtype; in US, bird flu has killed about 58 million birds, although human cases worldwide have remained very rare
Published: March 21, 2023 by Medical Daily
Patent Application Titled 'Immunogenic Composition' Published Online (USPTO 20230060184)
Published: March 17, 2023 by NewsRx Pharma Business Daily
GSK announces positive results from phase III trial of 5-in-1 meningococcal ABCWY vaccine candidate
Published: March 15, 2023 by PharmaBiz (India)

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count